Review
World J Hepatol
8(22):915-923.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.915
Abstract (1335)
|
Core Tip (1345)
|
Full Article (HTML) (4439)
|
Full Article (PDF)-777K (692)
|
Audio-357K (37)
|
Peer-Review Report-122K (221)
|
Answering Reviewers-64K (271)
|
Received: 02/20/2016
|
Revised: 04/22/2016
|
Accepted: 06/16/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (15)
|
Total Visits (13050)
|
Similar Articles (16)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implications
World J Hepatol
8(22):924-932.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.924
Abstract (1601)
|
Core Tip (1623)
|
Full Article (HTML) (14376)
|
Figures (1-4) (1954)
|
Full Article (PDF)-948K (1393)
|
Audio-1310K (40)
|
Peer-Review Report-106K (463)
|
Answering Reviewers-19K (314)
|
Received: 03/31/2016
|
Revised: 06/07/2016
|
Accepted: 07/13/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (63)
|
Total Visits (29958)
|
Similar Articles (508)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Antifibrotic effects of ambrisentan, an endothelin-A receptor antagonist, in a non-alcoholic steatohepatitis mouse model
World J Hepatol
8(22):933-941.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.933
Abstract (1470)
|
Core Tip (1468)
|
Full Article (HTML) (5388)
|
Figures (1-2) (429)
|
Tables (1-2) (411)
|
Full Article (PDF)-1246K (798)
|
Audio-442K (34)
|
Peer-Review Report-131K (398)
|
Answering Reviewers-120K (248)
|
Received: 03/02/2016
|
Revised: 04/27/2016
|
Accepted: 07/13/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (11)
|
Total Visits (20150)
|
Similar Articles (16)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
Living donor liver transplantation for high model for end-stage liver disease score: What have we learned?
World J Hepatol
8(22):942-948.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.942
Abstract (1349)
|
Core Tip (1360)
|
Full Article (HTML) (4355)
|
Figures (1-3) (435)
|
Tables (1-1) (427)
|
Full Article (PDF)-814K (595)
|
Audio-757K (32)
|
Peer-Review Report-105K (303)
|
Answering Reviewers-109K (270)
|
Received: 03/15/2016
|
Revised: 05/02/2016
|
Accepted: 07/13/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (18494)
|
Similar Articles (34)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
World J Hepatol
8(22):949-956.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.949
Abstract (1414)
|
Core Tip (1448)
|
Full Article (HTML) (4146)
|
Tables (1-3) (423)
|
Full Article (PDF)-799K (550)
|
Audio-1969K (25)
|
Peer-Review Report-132K (274)
|
Answering Reviewers-50K (242)
|
Received: 02/23/2016
|
Revised: 06/23/2016
|
Accepted: 07/22/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (15969)
|
Similar Articles (9)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
